Table 3.
Complications during the study
| Preoperative complications (n = 43) | Postoperative complications (n = 37) | |||||
|---|---|---|---|---|---|---|
| Grade 1, 2 | Grade 3–5 | Grade 1, 2 | Grade 3–5 | |||
| Photosensitivity | 1 | 0 | 0.0 % | 0 | 0 | 0.0 % |
| Anorexia | 4 | 0 | 0.0 % | 5 | 1 | (Grade 4, 2.7 %) |
| Nausea | 4 | 0 | 0.0 % | 3 | 0 | 0.0 % |
| Diarrhea | 0 | 0 | 0.0 % | 1 | 0 | 0.0 % |
| Somnolence | 1 | 0 | 0.0 % | 0 | 0 | 0.0 % |
| Dizziness | 2 | 0 | 0.0 % | 1 | 0 | 0.0 % |
| Malaise | 2 | 0 | 0.0 % | 2 | 0 | 0.0 % |
| Respiratory failure | 0 | 0 | 0.0 % | 0 | 1 | (Grade 4, 2.7 %) |
| Dyspnea | 0 | 0 | 0.0 % | 5 | 1 | (Grade 4, 2.7 %) |
| Pulmonary fistula | 0 | 0 | 0.0 % | 2 | 0 | 0.0 % |
| Postoperative hemorrhage | 0 | 0 | 0.0 % | 1 | 0 | 0.0 % |
| Cough | 0 | 0 | 0.0 % | 1 | 0 | 0.0 % |
| Atrial fibrillation | 0 | 0 | 0.0 % | 1 | 0 | 0.0 % |
| Wound dehiscence | 0 | 0 | 0.0 % | 1 | 0 | 0.0 % |
| Pneumonitis | 0 | 0 | 0.0 % | 0 | 1 | (Grade 5, 2.7 %) |
| Dysgeusia | 0 | 0 | 0.0 % | 1 | 0 | 0.0 % |
| White blood cell decreased | 0 | 0 | 0.0 % | 2 | 0 | 0.0 % |
| Neutrophil count decreased | 0 | 0 | 0.0 % | 1 | 0 | 0.0 % |
| Anemia | 2 | 0 | 0.0 % | 4 | 0 | 0.0 % |
| Hypoalbuminemia | 2 | 0 | 0.0 % | 19 | 0 | 0.0 % |
| ALP increased | 2 | 0 | 0.0 % | 8 | 0 | 0.0 % |
| Blood bilirubin increased | 0 | 0 | 0.0 % | 1 | 0 | 0.0 % |
| AST increased | 3 | 0 | 0.0 % | 8 | 1 | (Grade 3, 2.7 %) |
| ALT increased | 3 | 0 | 0.0 % | 6 | 0 | 0.0 % |
| GGT increased | 5 | 0 | 0.0 % | 6 | 0 | 0.0 % |
| Creatinine increased | 1 | 0 | 0.0 % | 0 | 0 | 0.0 % |
| Hyponatremia | 3 | 0 | 0.0 % | 8 | 1 | (Grade 3, 2.7 %) |
| Hyperkalemia | 1 | 0 | 0.0 % | 0 | 0 | 0.0 % |
| Hypokalemia | 0 | 0 | 0.0 % | 3 | 0 | 0.0 % |
| Hypocalcemia | 0 | 0 | 0.0 % | 3 | 0 | 0.0 % |
ALP alkaline phosphatase, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT γ-glutamyltransferase